Compare AureoGen vs Nanion Technologies GmbH
Customers evaluate the quality of AureoGen's products using the following success metrics.
Overview
AureoGen is based in United States
AureoGen is a research-based biotech company with a focus on discovery and production of commercially and clinically important cyclic peptide-based drugs, through genetic engineering of cyclic peptide producing organisms (as an alternative to complex and expensive synthetic chemistry methods). AureoGen's business is centered on generating intellectual property, both through discovery of genes, molecules and organisms and through development of technology and engineered organisms.
Nanion Technologies GmbH is 22 yrs old and is based in Germany.
Nanion Technologies is a spin-off company from the Center of Nanoscience (CeNS) of the University of Munich (LMU). anion combines bio- and microtechnology in a company serving the life sciences industry by offering products and services which will increase the speed and efficiency of the drug discovery process in an important segment of the pharmaceutical market. anion bases its business on a chip technology and will design and develop High Throughput Screening (HTS) systems for ion channel active drugs (ICADs). Ion channels are prime targets for medicines aimed at many important diseases.
Demo Video
Leadership
Ake Elhammer (Founder, Chief Executive Officer)
Niels Fertig (Chief Executive Officer, Owner)
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because AureoGen has not claimed their profile.
Work for AureoGen? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for AureoGen?
Claim your profile now.
Information not available because Nanion Technologies GmbH has not claimed their profile.
Work for Nanion Technologies GmbH? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Nanion Technologies GmbH?
Claim your profile now.
Expert Collections
Synthetic Biology
238 items
Companies involved in design and development of new biological parts, devices, and systems; as well as the re-design of existing biological systems.